Oncowitan logo (white)
  • About us
  • Our offer
    • Scientific writing & evaluation
    • Pharma projects
    • CDMO support
  • News
    • CDMO
    • Publications
  • [Gallery]

Gallery

Gallery

Antipressine® (dimethylaminoethanol reserpilinate and hydrobentizide), from Laboratoires Latéma (Paris), 1971

(more…)

By Christian Bailly, 3 years12 September 2022 ago
Gallery

Neuleptil® (propericiazine), from SPECIA (Paris), 1972

(more…)

By Christian Bailly, 3 years30 August 2022 ago
News-Publications

New publication: A group of triterpenoid natural products (alisols) with marked anti-inflammatory properties, mainly used to treat vascular diseases.

(more…)

By Christian Bailly, 3 years30 August 2022 ago
Gallery

Péritrate®, from Laboratoires Substantia (Suresnes, F), and Cardiwell®, from Laboratoire Wellcome (Paris, F), 1972 (erythrityl tetranitrate).

(more…)

By Christian Bailly, 3 years24 August 2022 ago
News-Publications

New publication: A potential repositioning of the aldose reductase inhibitor Epalrestat to treat cancers.

(more…)

By Christian Bailly, 3 years24 August 2022 ago
News-Publications

New publication: Opportunities and challenges associated with the targeting of GTPase Rac1.

(more…)

By Christian Bailly, 3 years13 August 2022 ago
Gallery

Soripal® (metiazinic acid), from SPECIA (Rhône-Poulenc, Paris, F), 1971

(more…)

By Christian Bailly, 3 years9 August 2022 ago
News-Publications

New publication: Bioactive para-terphenyl natural products isolated from Thelephora fungi.

(more…)

By Christian Bailly, 3 years9 August 2022 ago
Gallery

Toplexil® (oxomemazine, guaifenesin), from Laboratoires Specia (Paris), 1972

(more…)

By Christian Bailly, 3 years23 July 2022 ago
Gallery

Tomanol® (ramifenazone and phenylbutazone), from Laboratoire Négatol (Paris), 1972

(more…)

By Christian Bailly, 3 years11 July 2022 ago

Posts navigation

Previous 1 … 9 10 11 … 25 Next
Search
  • Our partners
  • Contact
  • Legal notice
Hestia | Developed by ThemeIsle
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK